Active substance
Results for the substance metformin+saxagliptin+dapagliflozin
1 result
About this active substance
Metformin, saxagliptin, and dapagliflozin are medications used in the treatment of type 2 diabetes, with complementary mechanisms of action to control blood sugar levels. These are often prescribed together for patients who cannot maintain adequate glycemic control through diet, exercise, or other antidiabetic medications alone.
Metformin is a first-line medication that reduces glucose production in the liver and improves insulin sensitivity. Saxagliptin is a DPP-4 inhibitor that increases incretin levels, hormones that stimulate insulin secretion and reduce glucagon release. Dapagliflozin, an SGLT-2 inhibitor, helps eliminate excess glucose through urine, thereby lowering blood sugar and providing additional benefits such as weight loss and blood pressure reduction.
The combination of these medications is effective in reducing glycated hemoglobin (HbA1c) and preventing diabetes-related complications, such as cardiovascular diseases. However, their use may be associated with side effects, such as urinary or gastrointestinal infections, and regular monitoring is essential for patient safety.
This combination therapy is recommended for patients with type 2 diabetes who require stricter glycemic control. It is important for patients to follow their doctor’s instructions and adopt a healthy lifestyle to maximize the benefits of the treatment.
Metformin is a first-line medication that reduces glucose production in the liver and improves insulin sensitivity. Saxagliptin is a DPP-4 inhibitor that increases incretin levels, hormones that stimulate insulin secretion and reduce glucagon release. Dapagliflozin, an SGLT-2 inhibitor, helps eliminate excess glucose through urine, thereby lowering blood sugar and providing additional benefits such as weight loss and blood pressure reduction.
The combination of these medications is effective in reducing glycated hemoglobin (HbA1c) and preventing diabetes-related complications, such as cardiovascular diseases. However, their use may be associated with side effects, such as urinary or gastrointestinal infections, and regular monitoring is essential for patient safety.
This combination therapy is recommended for patients with type 2 diabetes who require stricter glycemic control. It is important for patients to follow their doctor’s instructions and adopt a healthy lifestyle to maximize the benefits of the treatment.